Dishman acquires Creapharm Parenterals for undisclosed amount

18 Jan 2012 Evaluate

Dishman Pharmaceuticals and Chemicals Switzerland-based subsidiary Carbogen Amcis AG has acquired Creapharm Parenterals for an undisclosed amount. As part of this acquisition, Creapharm Parenterals, a contract development and manufacturing firm, has changed its name to Carbogen Amics SAS. The acquisition will extend Carbogen Amics development and manufacturing services by adding complementary formulation and lyophilisation services and sterile GMP capabilities for the fast supply of drug products, including highly potents, for pre-clinical studies and clinical trials (Phase I, II & III).

Peers
Company Name CMP
Sun Pharma Inds. 1520.15
Dr. Reddys Lab 6250.00
Cipla 1406.10
Zydus Lifesciences 955.00
Lupin 1626.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.